Will Ulta Beauty's FY2026 full-year operating margin exceed 14.0%?
Current Prediction
Prediction History
FY2026 guidance of flat-to-+20bps operating margin (12.4-12.6%) makes >14.0% near-impossible. Management explicitly did not promise margin recovery, guiding SG&A in line with sales growth. Even maximum guidance beat scenarios fall short of 14%.
Why This Question Matters
Full-year margin recovery above 14% is the critical test of the transformation premium thesis. The Moat Mapper identified this threshold as the dividing line between recoverable moat narrowing and structural competitive erosion. The Myth Meter found DEMANDING expectations require margin recovery that has not yet begun. If FY2026 margins exceed 14%, it would validate that Space NK integration costs and cloud tech amortization were transitory. Continued decline would confirm the moat narrowing is permanent and the premium is unjustified.
Prediction Distribution
Individual Predictions(9 runs)
FY2026 guidance removes virtually all ambiguity. Management guided FY2026 operating margin at flat to +20 bps vs FY2025's 12.4%. That implies 12.4-12.6% — nowhere near 14.0%. Achieving >14% would require ~160 bps above the midpoint of management's own guidance, which would be an unprecedented positive guidance miss of that magnitude. Management explicitly guided SG&A 'in line with to slightly below sales growth,' meaning no structural SG&A reduction is planned. The new CFO's language was 'disciplined cost management' and '4-wall productivity' — optimization, not transformation. Q4 SG&A deleveraged +230 bps to 25.7%, confirming the structural cost problem persists even in the holiday quarter. The 13% stock decline signals the market reached the same conclusion: margin recovery is not happening in FY2026.
The math is now definitive. FY2025 operating margin: 12.4%. FY2026 guidance: flat to +20 bps. Even if Ulta beats guidance by a full 100 bps (which would be an extraordinary beat), that gets to ~13.5% — still below 14.0%. The full-year SG&A deleverage (+17.4%) and Q4's +23% SG&A growth confirm the cost base is structurally higher. Management's FY2026 guidance of 6-9% operating profit growth on 6-7% sales growth implies minimal operating leverage. New CFO offered no quantified SG&A targets, only directional commentary. The Analyst Day (if it happens) could announce plans, but execution in FY2026 would only begin mid-year at best. The probability is near-zero but I leave room for an extreme scenario where Space NK suddenly becomes very profitable or a major cost item falls away unexpectedly.
I want to consider what tail scenario could produce >14%. It would require: (a) massive comp acceleration well above guided 2.5-3.5% driving natural SG&A leverage, AND (b) Space NK integration costs normalizing, AND (c) cloud amortization rolling off, AND (d) gross margin expansion beyond flat guidance. All four simultaneously seems extremely unlikely given management just guided against it. The FY2025 result confirmed the prior prediction's thesis: structural SG&A headwinds overwhelm gross margin improvement. FY2025 gross margin improved 30 bps to 39.1% but operating margin stayed at 12.4% — the improvement was absorbed by SG&A. This dynamic is explicitly expected to continue in FY2026 per guidance. The resolved sibling market (Q4 operating margin above 12.0% — resolved NO with Brier 0.09) confirms the committee's calibration was good, and that same analytical framework says >14% FY2026 is near-impossible.
Management's own FY2026 guidance of flat-to-+20bps operating margin makes >14.0% virtually impossible through normal business operations. FY2025 landed at 12.4%, and management is guiding ~12.5% for FY2026. The gap to 14% is 150-160 bps — management would need to miss their own guidance by an enormous margin to the upside. EPS guidance of $28.05-$28.55 (9-11% growth) implies steady improvement, not a step-function margin recovery. SG&A growth guided 'in line with to slightly below' sales growth means no significant SG&A ratio improvement is expected. Stock's 13% decline confirms the market sees no near-term margin recovery catalyst.
While guidance strongly points to NO, I want to account for uncertainty over a full fiscal year. FY2026 doesn't report until March 2027 — that's 12 months away. Could Ulta dramatically outperform? The Analyst Day hasn't happened yet and could introduce a major restructuring. New CFO from outside could bring a different cost philosophy. H2 FY2026 is expected to show stronger profit growth as Space NK/investment costs lap. But even with these upside scenarios, the starting point (12.4%) and the guided trajectory (flat to +20 bps) make 14% a true outlier. I weight this slightly higher than pure guidance math suggests because of the long time horizon and potential for an Analyst Day catalyst, but it remains very low probability.
FY2026 operating profit growth guided at 6-9% on 6-7% sales growth. Operating profit = operating margin × revenue. If revenue grows 6.5% to ~$13.2B and operating profit grows 7.5% to ~$1.66B, that implies operating margin of ~12.6%. Even at the high end (9% profit growth, 6% sales growth), operating margin would be ~12.7%. The math simply does not reach 14.0% under any reasonable interpretation of guidance. The only path to YES is a massive, unguided positive surprise — perhaps a significant asset sale, one-time gain, or accounting reclassification. These are tail events with very low probability.
FY2026 guidance directly answers this question: operating margin flat to +20 bps from 12.4% = 12.4-12.6%. That's 140-160 bps below the 14.0% threshold. Management is telling us this won't happen. SG&A not being restructured. New stores adding costs. Space NK integration ongoing. Near-zero probability outside extreme tail scenarios.
Math is clear. FY2025 operating margin: 12.4%. Guidance: flat to +20 bps. Even maximum guidance beat scenario doesn't reach 14%. Four consecutive years of decline now confirmed (16.1% → 15.0% → 13.9% → 12.4%). The trajectory is still down, just slowing. Management guided comp +2.5-3.5% which provides less operating leverage than FY2025's +5.4%. This is firmly a NO market.
FY2025 confirmed at 12.4% operating margin. FY2026 guided 12.4-12.6%. Management explicitly not promising margin recovery. New CFO's tone is 'disciplined' not 'transformational.' Q4 SG&A deleveraged 230 bps even in strong holiday quarter. 50-60 new stores adding costs. $1B buyback program focuses capital on buybacks not margin improvement. Probability near floor.
Resolution Criteria
Resolves YES if Ulta Beauty's full-year FY2026 (fiscal year ending January/February 2027) GAAP operating income as a percentage of net sales exceeds 14.0%, as reported in the FY2026 10-K or Q4 FY2026 earnings press release. Resolves NO if operating margin is 14.0% or below.
Resolution Source
Ulta Beauty FY2026 10-K filing or Q4 FY2026 earnings press release (expected March 2027)
Source Trigger
Operating margin recovery to >14% annual rate
Full multi-lens equity analysis